Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome

Neurology

Volumn 79, Issue 10, 2012, Pages 1033-1040

  Lossin, Christoph ^a   Nam, Tai Seung ^b   Shahangian, Shahab ^a   Rogawski, Michael A ^a   Choi, Seok Yong ^c   Kim, Myeong Kyu ^b   Sunwoo, Il Nam ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Chonnam National University   (South Korea)

^c Department of Neurology ^*  (South Korea)

^d Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; SODIUM CHANNEL NAV1.4;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; FEMALE; HUMAN; HUMAN TISSUE; HYPOKALEMIC PERIODIC PARALYSIS; KOREA; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CURRENT; THOMSEN DISEASE; VOLTAGE CLAMP; WILD TYPE;

EID: 84866135637     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182684683     Document Type: Article

References (28)

1. Ptacek LJ, Trimmer JS, Agnew WS, Roberts JW, Petajan JH, Leppert M. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodiumchannel gene locus. Am J Hum Genet 1991;49:851-854.
2. Fan Z, George AL Jr, Kyle JW, Makielski JC. Two human paramyotonia congenita mutations have opposite effects on lidocaine block of Na channels expressed in a mammalian cell line. J Physiol 1996;496:275-286.
3. Miller TM. Differential diagnosis of myotonic disorders. Muscle Nerve 2008;37:293-299.
4. Chahine M, George AL Jr, Zhou M, et al. Sodium channel mutations in paramyotonia congenita uncouple inactivation from activation. Neuron 1994;12:281-294.
5. Groome JR, Larsen MF, Coonts A. Differential effects of paramyotonia congenita mutations F1473S and F1705I on sodium channel gating. Channels (Austin) 2008;2:39-50.
6. Carle T, Fournier E, Sternberg D, Fontaine B, Tabti N. Cold-induced disruption of Na+ channel slow inactivation underlies paralysis in highly thermosensitive paramyotonia. J Physiol 2009;587:1705-1714.
7. Jurkat-Rott K, Holzherr B, Fauler M, Lehmann-Horn F. Sodium channelopathies of skeletal muscle result from gain or loss of function. Pflugers Arch 2010;460:239-248.
8. Lehmann-Horn F, Orth M, Kuhn M, Jurkat-Rott K. A novel N440K sodium channel mutation causes myotonia with exercise-induced weakness: exclusion of CLCN1 exon deletion/duplication by MLPA. Acta Myol 2011;30:133-137.
9. Fournier E, Arzel M, Sternberg D, et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 2004;56:650-661.
10. Jackson CE, Barohn RJ, Ptacek LJ. Paramyotonia congenita: abnormal short exercise test, and improvement after mexiletine therapy. Muscle Nerve 1994;17:763-768.
11. Fournier E, Viala K, Gervais H, et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol 2006;60:356-365.
12. Amato AA, Russell JA. Neuromuscular Disorders. New York: McGraw-Hill; 2008:655-680.
13. Richmond JE, Featherstone DE, Ruben PC. Human Na channel fast and slow inactivation in paramyotonia congenita mutants expressed in Xenopus laevis oocytes. J Physiol 1997;499:589-600.
14. Bendahhou S, Cummins TR, Kula RW, Fu YH, Ptacek LJ. Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5. Neurology 2002;58:1266-1272.
15. Cummins TR, Sigworth FJ. Impaired slow inactivation in mutant sodium channels. BiophysJ 1996;71:227-236.
16. Ruff RL. Slow Na channel inactivation must be disrupted to evoke prolonged depolarization-induced paralysis. BiophysJ 1994;66:542.
17. Bendahhou S, Cummins TR, Kwiecinski H, Waxman SG, Ptacek LJ. Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans. J Physiol 1999;518:337-344.
18. Tahmoush AJ, Schaller KL, Zhang P, Hyslop T, Heiman-Patterson T, Caldwell JH. Muscle sodium channel inactivation defect in paramyotonia congenita with the Thr1313Met mutation. Neuromuscul Disord 1994;4:447-454.
19. Bouhours M, Sternberg D, Davoine CS, et al. Functional characterization and cold sensitivity of T1313A, a new mutation of the skeletal muscle sodium channel causing paramyotonia congenita in humans. J Physiol 2004;554:635-647.
20. Plassart-Schiess E, Lhuillier L, George AL Jr, Fontaine B, Tabti N. Functional expression of the Ile693Thr Na channel mutation associated with paramyotonia congenita in a human cell line. J Physiol 1998;507:721-727.
21. Featherstone DE, Fujimoto E, Ruben PC. A defect in skeletal muscle sodium channel deactivation exacerbates hyperexcitability in human paramyotonia congenita. J Physiol 1998;506:627-638.
22. Matthews E, Tan SV, Fialho D, et al. What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed. Neurology 2008;70:50-53.
23. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channelopathies. Neurol Sci 2005;26:194-202.
24. de Silva SM, Kuncl RW, Griffin JW, Cornblath DR, Chavoustie S. Paramyotonia congenita or hyperkalemic periodic paralysis? Clinical and electrophysiological features of each entity in one family. Muscle Nerve 1990;13:21-26.
25. Sheets PL, Heers C, Stoehr T, Cummins TR. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-iV- benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharmacol Exp Ther 2008;326:89-99.
26. Rajamani S, Shryock JC, Belardinelli L. Block of tetrodotoxin-sensitive, NaV17 and tetrodotoxin-resistant, NaV18, Na channels by ranolazine. Channels (Austin) 2008;2:449-460.
27. V1.4 sodium channels and paramyotonia congenita mutants. Channels (Austin) 2011;161-172.
28. Bennett RL, Steinhaus KA, Uhrich SB, et al. Recommendations for standardized human pedigree nomenclature: Pedigree Standardization Task Force of the National Society of Genetic Counselors. Am J Hum Genet 1995;56:745-752.